Updated:
Neil A Burns
Neil Burns runs a private equity firm focused on surfactants and specialty chemicals, sourcing divestitures, buyouts, and spin-offs globally.
Neil A Burns
Neil A Burns operates from Freehold, New Jersey, as a private equity vehicle targeting the global surfactants and specialty chemicals industry. The firm's posture emerges directly from its principal's deep sector immersion: Burns publishes *Surfactants Monthly*, a widely read industry blog that tracks raw-material pricing, regulatory shifts, and M&A activity across the alkoxylation, methacrylate, and bio-based surfactant markets. Investment strategies span divestitures, management buyouts, recapitalizations, and spin-offs within the chemicals midstream. The firm appears to target specialty-chemical manufacturing assets with global-scale capabilities. Burns's public commentary flagged Endless LLP's acquisition of GEO Specialty Chemicals UK Ltd. — a £68 million-revenue alkoxylation and silicone manufacturer — in January 2026, and noted Ballestra's sale to NextChem in December 2025 as a landmark process-technology deal. Geographic focus covers North America and Europe, with indirect exposure to Asia-Pacific through portfolio-company supply chains. Team size and AUM remain undisclosed. The firm does not operate visible affiliated foundations or co-investor clubs. Burns maintains an active industry-advocacy role: he spoke at the Council for Producers and Distributors of Agrotechnology meeting in Austin, Texas, in April 2026, and serves as a board advisor to Integrity BioChem, a commercial-scale producer of bio-based surfactants that launched an Australian mining-chemicals venture in September 2025 through ICD BioChem. The firm's structural differentiator is its principal's real-time industry-intelligence function. *Surfactants Monthly* functions as an always-on deal-sourcing and due-diligence engine — tracking BASF price hikes, EPA ethylene oxide deregulation, and consumer-goods volume declines — giving the firm an information advantage over generalist chemical investors who lack continuous, practitioner-level market surveillance.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Freehold
Corporate office
Freehold, NJ, United States
Principals
Neil A Burns
Principal
Sector focus
Frequently asked questions
Who runs investment decisions at Neil A Burns?
Neil Burns is the named principal and appears to drive all investment and sourcing decisions directly. His industry blog, *Surfactants Monthly*, serves as both a market-intelligence vehicle and a signal of his personal involvement in evaluating chemical-manufacturing assets. No additional investment committee or partners are publicly disclosed.
How does Neil A Burns source proprietary deal flow?
Deal flow is anchored to Burns's deep surfactant-industry network, including relationships with chemical producers such as Indovinya, Stepan, Croda, and Syensqo. His continuous publication of *Surfactants Monthly* and speaking engagements — such as the April 2026 CPDA meeting — keep him at the center of industry M&A discussions, allowing him to identify carve-outs and distressed specialty-chemical assets before broader auction processes.
Is Neil A Burns structured as a single family office or does it operate more like a venture firm?
It is categorized as a private equity firm, not a family office. It pursues control-oriented strategies — divestitures, management buyouts, recapitalizations, and spin-offs — in the specialty chemicals sector, which distinguishes it from venture capital or growth-equity models.
Does Neil A Burns participate in fund commitments or only direct deals?
The firm's disclosed strategy focuses on direct deals — divestitures, buyouts, and spin-offs. There is no public evidence of fund commitments or a fund-of-funds allocation program.
What investment stages does Neil A Burns typically target?
The firm targets mature industrial assets rather than early-stage ventures. Strategies include management buyouts, corporate divestitures, and recapitalizations of established specialty-chemical manufacturers with existing revenue streams and production capabilities.
How is Neil A Burns related to Integrity BioChem?
Neil Burns serves as a board advisor to Integrity BioChem, a producer of bio-based surfactants. This advisory role creates a direct link to one of the commercial leaders in the bio-surfactant field, though it does not necessarily imply an equity position by the firm.
Where does the underlying capital come from?
The source of the firm's investment capital is not publicly disclosed. No regulatory filings or press reports specify whether Burns deploys personal capital, institutional commitments, or partnership structures.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: